Business · 21/08/2013Updated: 10/17/2026 · 1 min read
FDA and EMA to Host Public Workshop on Orphan Product Designation and Grant
Summary
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) will host a public workshop to discuss orphan product designation and grant procedures, allowing public input and feedback.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →